ArticleAmerican journal of translational research2019

STOML2 as a novel prognostic biomarker modulates cell proliferation, motility and chemo-sensitivity via IL6-Stat3 pathway in head and neck squamous cell carcinoma.

Haiou Qu et al.PubMed ↗Full text ↗

No numbers read from the abstract.